Background In sub-Saharan Africa, little is known about the damage to respiratory health caused by biomass smoke and tobacco smoke. We assessed the prevalence of chronic obstructive pulmonary disease (COPD) and related risk factors in a rural region of Uganda.
Introduction
Non-communicable diseases have often been considered less important than communicable diseases in lowincome and middle-income countries. 1 However, chronic obstructive pulmonary disease (COPD), once regarded as a disease of high-income countries, is now recognised as common in low-income and middle-income countries. 2, 3 COPD is the fourth leading cause of death worldwide, and is predicted to become the third by 2020, surpassing the combined mortality for malaria, tuberculosis, and HIV/AIDS in Africa. [4] [5] [6] The main causes of COPD in high-income countries are tobacco smoke and occupational exposure, but in low-income and middle-income countries use of biomass fuel (wood, dung, crop residues, and charcoal) for cooking and domestic heating is also a major cause of COPD and childhood respiratory infections. 2, [7] [8] [9] Biomass fuels are often burned ineffi ciently in open fi res, leading to high levels of indoor air pollution, exceeding health limits specifi ed by international standards of ambient air quality. 7 Worldwide, biomass fuels are used in about 50% of households, exposing more than 3 billion people to their adverse eff ects. 9, 10 Other contributing risk factors for COPD in low-income and middle-income countries are a history of tuberculosis, untreated asthma, respiratory infections, kerosene-based lighting, and socioeconomic factors such as malnutrition and poverty. 5 In sub-Saharan Africa, particularly in rural regions, knowledge of COPD is very poor; many people (healthcare workers, government offi cials, and the public) are unaware of the damage to respiratory health caused by tobacco and biomass fuel smoke. 11 Data for the burden of COPD and related risk factors are scarce or not available. Some surveys have been done in Africa; 12 however, they have often been of poor quality-for example, COPD diagnosis based on the presence of symptoms rather than spirometry or bronchodilator use. 10, 12 Only two population studies have used appropriate methods and population-representative sampling. In 2007, the Burden of Lung Disease study 13 in South Africa showed a high prevalence of stage 2 or higher COPD (22·2% in men and 16·7% in women) in an urban population older than age 40 years, associated with previous tuberculosis and occupational exposure in addition to smoking. In 2008-09, a survey done in urban and rural Rwanda reported a COPD prevalence of 9·6% in people older than age 45 years. 14 We did a study (FRESH AIR Uganda) to assess the prevalence and burden of COPD and related risk factors in adults in a poor rural region of Uganda.
Methods

Study design and participants
We did this population-based, observational, crosssectional study between April 13, and Aug 14, 2012, in the rural district of Masindi (population 350 000) in Uganda, a low-income country with an average life expectancy of 52 years (48 years for men, 57 years for women). 15 25 local nurses and health offi cers were recruited as research assistants and received a 5-day training course in highquality spirometry. 16 We chose Masindi district because it had a stable population in a defi ned rural area and a functional health system. In collaboration with the National Bureau of Statistics in Uganda, we selected 30 villages with a probability proportional to their size. Each village contained an estimated 150 households; each household consisted of 1·5 adults on average. Selected villages were visited to count the households. In each village, 20 households were then selected, with simple random sampling using R statistical software. From the chosen households all eligible men and women were invited to participate.
Exclusion criteria were age younger than 30 years, history of any mental illnesses; myocardial infarction in the past 6 weeks; hospital admission for cardiac illnesses within the past 6 months; thoracic, abdominal, or eye surgery (or retinal detachment) in the past 6 weeks; active tuberculosis; pregnancy; and present lung infection (participants were included after recovery). Age 30 years was chosen as the cutoff to avoid missing people with premature airfl ow obstruction because exposure to biomass smoke starts during early childhood. [6] [7] [8] [9] [10] [11] The liaison offi cer from the district health offi ce visited the villages and, together with the village leader, explained the purpose of the survey to eligible participants. Each participant signed an informed consent form, or in case of illiteracy, thumb-printed and signed by a witness. The study was approved by the Makerere University School of Medicine Research and Ethics Committee and the Uganda National Council for Science and Technology.
Procedures
Weight and height were measured. A screening questionnaire, developed from diff erent validated questionnaires and adapted to local circumstances, was completed during a face-to-face interview (appendix). [17] [18] [19] The questions included tribal origin, education, occupation, living in tobacco-growing areas, respiratory symptoms (cough, sputum, wheezing, shortness of breath), Medical Research Council dyspnoea scale score, chest infections, tobacco use, biomass fuel use, cooking and sleeping areas, tuberculosis, comorbidities, drug treatments, admission to hospital, and visits to health centres.
All participants underwent spirometry after explanation by a research assistant in their local language. Spirometry was done in accordance with the American Thoracic Society and European Respiratory Society recom mendations: at least three acceptable and reproducible blows with the largest and second-largest values for both forced vital capacity (FVC) and forced expiratory volume in 1 s (FEV 1 ) within 150 mL or no more than 5% diff erence; the largest values for FVC and FEV 1 were considered the best and used for analysis. 6, 16 Spirometry was done while seated, using Pneumotrac with Spirotrac V software (version 1.06). A new fi lter was applied for each measurement to avoid contamination. Spirometers were calibrated every morning with a 1 L syringe and weekly with a biological control.
In most epidemiological surveys, COPD is defi ned by spirometry and few clinical characteristics. 20 This contrasts with clinical guidance recommending a diagnosis based on compatible spirometry and clinician's assessment of exposure to risk factors, symptoms, limitations, healthrelated quality-of-life, and exacerbations. 6, 16 We used a pre-bronchodilator FEV1:FVC ratio of less than 0·8 or an FVC of less than 80% as cutoff s for whether or not to do a post-bronchodilator assessment, to avoid underestimating FVC, which could result in a normal FEV 1 :FVC ratio. 21 Participants took a short-acting bronchodilator (salbutamol 200 μg) administered with a Redihaler (to avoid possible infections with a spacer) and spirometry was repeated 15 min thereafter. All spirometry results were reviewed weekly by the investigators; those which did not meet the quality criteria were repeated.
The Global Initiative for Chronic Obstructive Lung Disease defi nition of airfl ow obstruction includes a fi xed FEV 1 :FVC ratio of less than 0·7 after administration of an inhaled bronchodilator. 6 Because this defi nition could lead to over-diagnosis in elderly participants and under-diagnosis in young participants, we used a lower limit of normal threshold to defi ne COPD-ie, participants below the fi fth percentile of the predicted FEV 1 :FVC ratio (calculated with GLI2012 DataConversion software; version 3.3.1). [22] [23] [24] Classifi cation of severity of COPD was based on the Global Initiative for Chronic Obstructive Lung Disease criteria: mild obstruction, FEV 1 ≥80%; moderate obstruction, FEV 1 50-79%; severe obstruction, FEV 1 30-49%; and very severe obstruction, FEV 1 <30%. 6, 20 See Online for appendix
We assessed health-related quality-of-life with the Clinical COPD Questionnaire, a ten-item questionnaire divided into three domains (symptoms, mental state, and functional state) and translated to the main local languages. 25 The fi nal mean score of the Questionnaire was calculated, with a higher score representing worse health status. 6, 20 
Statistical analysis
The intended sample size was 600 participants, calculated to give an acceptable degree of reliability for estimating prevalence (for an estimate prevalence of 15%, 95% CI 12·1-17·9). 13 We compared COPD prevalence in men and women with a χ² test. We did univariate analyses to evaluate associations between COPD and possible risk factors, selected on basis of previously studies. 2, 3, 6 For normally distributed variables we used Student's t tests and Pearson correlation coeffi cient, and for non-normally distributed variables we used Mann-Whitney U tests and Spearman's correlation coeffi cient. The risk factors were age, sex, occupation, wheeze, cough, shortness of breath, smoking status, pack years, time cooking indoors, time cooking outdoors, respiratory infections, asthma, heart failure, tuberculosis, and socioeconomic factors. We included risk factors that had a p value lower than 0·2 in the univariate analyses in subsequent multivariate regression analysis using the backward Wald method. 26 Selection of the logistic models was based on Nagelkerke's R², Hosmer-Lemeshow test, and the receiver operating characteristic curve. We considered p values less than 0·05 as statistically signifi cant and p values of 0·05-0·1 as trends. We did the statistical analysis with SPSS (version 20).
Role of the funding source
The funder of the survey had no role in study design, data collection, data analysis, data interpretation, or writing of the report. The corresponding author had full access to all the data and had fi nal responsibility for the decision to submit for publication.
Results
Of the 620 people invited to participate, 609 underwent spirometry (fi gure 1). 588 (97%) of 609 people (291 men and 297 women) provided acceptable spirometry (fi gure 1). We detected no statistically signifi cant diff erences between the 588 people with acceptable spirometry and the 21 people without acceptable spirometry in terms of age, sex, smoking behaviour, and tuberculosis infection (data not shown). Mean age was 45·2 years (SD 13·6); 414 (70%) participants were aged 30-49 years. 485 (83%) lived in rural areas and 440 (75%) were farmers. Electricity was not available for 545 (93%) participants; 552 (94%) used kerosene-based lighting.
Almost all participants, both men and women, were exposed to biomass smoke, indoor as well as outdoor (table 1) . In 521 (98%) of 546 exposed participants, wood was the main solid fuel for cooking, used in an open fi re.
Smoking was more common in men than in women (table 1), particularly among young men: 52 (52%) of 100 male smokers were younger than 39 years (data not shown).
According to the defi nition of COPD as FEV 1 :FVC less than the lower limit of normal, the prevalence of COPD According to the Global Initiative for Chronic Obstructive Lung Disease criterion, COPD prevalence was 12·4% (73 of 588 participants); 32 (43·8%) were women. Mean age of COPD patients using this criterion was 55·5 years (SD 14·7); 11 (15·1%) were aged 30-39 years and 15 (20·5%) were older than 70 years (appendix).
Mean Clinical COPD Questionnaire score was 0·81 (SD 0·78); the mean score for the symptoms domain was 1·09 (SD 0·95), for the mental state domain it was 0·60 (SD 1·03), and for the functional state domain it was 0·64 (SD 0·88; table 2). The mean Medical Research Council dyspnoea score was 1·33 (SD 0·66) for participants with COPD, and 1·31 (SD 0·59) for participants without COPD. One or more exacerbations within the previous 12 months were reported by 28 (29·5%) of 95 participants with COPD, increasing with age (20% for people aged 30-39 years, 23% for people aged 40-49 years, 23% for people aged 50-59 years, 67% for those aged 60-69 years, and 57% for people aged >70 years). About a fi fth of participants with COPD had two or more exacerbations in the past 12 months (table 3) . The appendix shows the relation between airfl ow obstruction, cough, and dyspnoea score of 2 or more. 546 (92·9%) of 588 participants were exposed to indoor biomass smoke and 544 (92·5%) were exposed to outdoor biomass smoke. Univariate analysis showed that exposure did not diff er signifi cantly between COPD and non-COPD participants (table 3) . The univariate analysis also showed that smoking status was associated with COPD (table 3) . Cough and wheeze were signifi cantly more common in patients with COPD than in participants without COPD (appendix). Heart failure was also signifi cantly associated with COPD (table 3) . We detected no signifi cant diff erences between participants with and without COPD with regards to age, sex, education, tribal origin, asthma, chest infections, living in a tobacco-growing area, type of cooking area, hospital admission in the past 2 years, and health centre visits in the past 2 years. Too few participants had HIV/AIDS or tuberculosis to assess associations for these diseases. We detected a correlation between age and years of exposure to biomass smoke (indoors r=0·564, p<0·0001 and outdoors r=0·603, p<0·0001), and age and dyspnoea score (r=0·291, p<0·0001). Women were more exposed than were men to biomass smoke, both indoors and outdoors and both in terms of hours per day and number of years (all p<0·0001).
Univariate analyses within sexes showed an association with COPD among men with more than two chest infections per year, and a trend among men in villages in tobacco-growing areas (table 3) .
Among participants with COPD, 20 (44%) of 45 men and four (8%) of 50 women were current smokers; their mean age was 40·4 years for men and 52·0 years for women (65% of men compared with 5% of women aged 30-39 years were current smokers). 11 (24%) men and nine (18%) women were former smokers; their mean age was 48·6 years and 63·8 years, respectively (fi gure 3).
Logistic regression analyses showed an association of wheeze and being a former smoker with the presence of COPD; cough, current smoker, heart failure, and hours per day cooking indoors showed trends for association with COPD (table 4) .
Non-COPD (n=493) COPD (n=95) p value (non-COPD vs COPD)
Men ( 
Discussion
FRESH AIR Uganda was one of the fi rst populationbased, randomised, cross-sectional surveys done in a rural area of a sub-Saharan country focused on the prevalence and burden of COPD, an unknown disease in the community (panel). The prevalence of spirometry-defi ned COPD in people older than 30 years was 16%; 39% of them, both men and women, were aged 30-39 years. Where present, airfl ow obstruction was not generally severe; the same applied to symptoms, health-related quality of life, and dyspnoea score. The relevance of asymptomatic airfl ow obstruction in this population is not yet known. However, a fi fth of participants with airfl ow obstruction had two or more exacerbations in the past 12 months.
Almost everybody was exposed to biomass smoke, mainly caused by wood fi res in poorly ventilated indoor cooking areas. 11 Cigarette smoking was prominent in young men. Young women hardly smoked at all. 11 In villages situated among tobacco-growing fi elds, the leaves were often dried indoors using an open fi re and guarded by elderly people and young children. 11 Most people-both children and adults-were also exposed to the pollutants 
Systematic review
In 2011, a systematic review was done of the prevalence and eff ect of asthma and chronic obstructive pulmonary disease (COPD) in sub-Saharan Africa. 10 119 reports were identifi ed: 32 of asthma, 18 of COPD, 59 of indoor air pollution, and ten of primary care, with some overlap. The limited data showed that the burden of asthma and COPD was rising. 2,10 These diseases had not been thought of as major health problems. Tobacco smoking was an important risk factor for COPD worldwide, but exposure to biomass fuel could be even greater in sub-Saharan Africa. 9, 10 In 2012, a qualitative survey was done in a rural district of Uganda to explore beliefs and attitudes about respiratory symptoms, use of biomass fuel, tobacco smoking, and use of health services. 11 The lack of knowledge (the word "COPD" was totally unknown) created diff erent beliefs and attitudes about respiratory symptoms. Most people used biomass fuels to cook and were unaware of the damage to respiratory health caused by tobacco and biomass smoke.
Interpretation
In our study, the prevalence of spirometry-defi ned COPD in people older than age 30 years was 16·2%. The prevalence was especially high (39%) in people aged 30-39 years. Whole families are exposed to biomass smoke, mainly caused by wood fi res in poorly ventilated cooking areas, starting at early age (even in utero). The high prevalence of COPD, especially in young people, suggests a hidden health problem and the potential for major consequences in the future. Our fi ndings suggest that a major priority should be prevention of exposure by promotion of awareness of the harmful eff ects of biomass fuel use and tobacco smoke in all communities, and among health-care workers and policy makers. Environmental toxins caused by biomass fuel, tobacco smoke, kerosene lamps, and occupational exposure should be controlled. 5 Simple ventilation, including energy-saving stoves and retained-heat cookers, can greatly reduce air pollution. Education is needed for behavioural changes. 5 Public health and clinical researchers should work together to improve knowledge of early detection, diagnosis, and treatment of COPD and to reduce the present and future burden of chronic lung disease on health systems. These interventions will benefi t people at risk of all smoke-attributable morbidity and mortality, not just COPD. from kerosene-based lighting, an under-rated risk factor for lung damage. 27, 28 We detected a strong correlation between age and the amount of biomass smoke exposure. However, we could not detect a diff erence in COPD prevalence in relation to biomass exposure because exposure was so common that we lacked a suffi cient number of unexposed people to act as a control group. By contrast with results from other large prevalence surveys, often done in urban areas with participants older than 40 years, 3,6,29 age and sex were not signifi cantly associated with COPD in our survey. A major contributor to these results could be the low average life expectancy in Uganda.
Odds ratio (95% CI) p value
Our study has several limitations. Spirometry was not always done in an ideal environment; nevertheless, the results were evaluated in accordance with American Thoracic Society and European Respiratory Society criteria. 6 Appropriate spirometry reference values from east Africans did not exist at the time of the survey. We used African and south Indian reference values from 1993. 30 In Uganda, as in many countries in Africa, until at least a decade ago, registration births was often incomplete. People often knew their year of birth, but did not know their exact birth date (29% of participants reported being born on Jan 1). The diagnosis of COPD could be diffi cult in sub-Saharan Africa, where the prevalence of comorbid respiratory infections, such as tuberculosis, is high. However, the prevalence of tuberculosis was low in our study site so we could not detect no association with COPD. Likewise, we could not test for an association between HIV infection and COPD. In rural areas the prevalence of asthma is low compared with urban areas. 10, [31] [32] [33] Eight patients with COPD had a change in FEV 1 of more than 12% and 200 mL after a bronchodilator; none of them were known to have asthma.
By contrast with the FEV 1 and FVC, which are aff ected by race and ethnic origin, the FEV 1 :FVC ratio is generally independent of ethnic group and therefore does not require specifi c reference values. 23, 34 Using GLI2012 DataConversion software, we could defi ne the lower limit of normal for the FEV 1 :FVC ratio with reasonable confi dence without reference values for FEV 1 and FVC. 35 The lower limit of normal as a criterion made possible the identifi cation younger people with an airfl ow obstruction.
Biomass smoke causes low birthweight and poor lung growth, inducing respiratory infections in early childhood and causing large and lasting eff ects into adulthood, leading to decline of lung function, and substantially increasing the risk of COPD. [6] [7] [8] [9] Tobacco smoke combined with exposure to smoke from biomass fuel might even have an additive eff ect on the risk of COPD. 6, 9 Further research is needed to understand the shortterm and long-term eff ects of these risk factors, and their association in the early development of COPD. Particularly, the progression of airfl ow obstruction over time needs to be better understood to discover what stage in life exposure causes most pulmonary damage. A new approach to prevention of lung disease is needed to combine education and support, to reduce exposures, and recognise and diagnose lung diseases at an early stage to minimise their eff ect. Further research is also needed into aff ordable and eff ective interventions for COPD. COPD could be a major health threat to men and women in rural areas of Uganda.
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